Publications

Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

 91
Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

Tags:

Previous Article

ALS drug effectively treats Alzheimer’s disease

Next Article

Inhibition of ceramide synthesis contributes to cardiometabolic diseases

Related Posts

Feedforward miR-181d degradation modulates population variance of methyl-guanine methyl transferase and temozolomide resistance

Feedforward miR-181d degradation modulates population v...

 26

Metabolic cross-feeding of a dietary antioxidant enhances anaerobic energy metabolism by human gut bacteria

Metabolic cross-feeding of a dietary antioxidant enhanc...

 152

Foundation models for fast, label-free detection of glioma infiltration

Foundation models for fast, label-free detection of gli...

 67